SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: SONN, SKX, FCCO, and SGBG
Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) related to its merger with Rorschach I LLC. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company.
Click here for more information https://monteverdelaw.com/case/sonnet-biotherapeutics-inc. It is free and there is no cost or obligation to you.
Skechers U.S.A., Inc. (NYSE: SKX) related to its sale to Beach Acquisitions Co Parent. Upon completion of the proposed transaction, outstanding Skechers stock will be cancelled and converted into the right to receive either (i) $63.00 in cash or (ii) $57.00 in cash plus one limited liability company unit of Beach Acquisitions, depending the Skechers shareholder election and subject to proration.
Click here for more information https://monteverdelaw.com/case/skechers-u-s-a-inc/. It is free and there is no cost or obligation to you.
First Community Corporation (NASDAQ: FCCO) related to its merger with Signature Bank of Georgia. Upon completion of the proposed transaction, Signature Bank shareholders will receive 0.6410 shares of First Community common stock per Signature Bank share.
Click here for more information https://monteverdelaw.com/case/first-community-corporation/https://monteverdelaw.com/case/guaranty-bancshares-inc/. It is free and there is no cost or obligation to you.
Signature Bank of Georgia (OTCMKTS: SGBG) related to its merger with First Community Corporation. Upon completion of the proposed transaction, Signature Bank shareholders will receive 0.6410 shares of First Community common stock per Signature Bank share.
Click here for more information https://monteverdelaw.com/case/signature-bank-of-georgia/. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:
Do you file class actions and go to Court?
When was the last time you recovered money for shareholders?
What cases did you recover money in and how much?
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:Juan Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4740New York, NY 10118United States of Americajmonteverde@monteverdelaw.comTel: (212) 971-1341
Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
4 hours ago
- New Straits Times
Dotcom lessons loom over AI-fuelled Wall Street surge
WALL Street's concentration in the red-hot tech sector is, by some measures, greater than it has ever been, eclipsing levels hit during the 1990s dotcom bubble. But does this mean history is bound to repeat itself? The growing concentration in United States equities instantly brings to mind the Internet and communications frenzy of the late 1990s. The tech-heavy Nasdaq peaked in March 2000 before cratering 65 per cent over the following 12 months. And it didn't revisit its previous high for 14 years. It seems unlikely that we will see a repeat of this today, right? Maybe. The market's reaction function appears to be different from what it was during the dotcom boom and bust. Just look at the current rebound from its post-"Liberation Day" tariff slump in early April — one of the fastest on record — or its rally during the Covid-19 pandemic. But despite all of these differences, there are also some worrying parallels. Investors would do well to keep both in mind. The most obvious similarity between these two periods is the concentration of tech and related industries in US equity markets. The broad tech sector now accounts for 34 per cent of the S&P 500's market cap, according to some data, exceeding the previous record of 33 per cent set in March 2000. Of the top 10 companies by market capitalisation today, eight are tech or communications behemoths. They include Apple, Amazon, Alphabet, Meta, Microsoft, Nvidia and Tesla — as well as Berkshire Hathaway and JPMorgan. By contrast, only five of the 10 biggest companies in 1999 were tech firms. The other five were General Electric, Citi, Exxon, Walmart and Home Depot. Plus, the top 10 companies' footprint in the S&P 500 today is much larger than it was back then. The combined market cap of the top 10 today is almost US$22 trillion, or 40 per cent of the index's total, significantly higher than the comparable 25 per cent in 1999. This all reflects the fact that technology plays a much bigger role in the US economy today. By some measures, the current tech boom, driven in part by enthusiasm for artificial intelligence (AI), is more extreme than the information technology bubble of the late 1990s. As Torsten Slok, chief economist at Apollo Global Management, points out, the 12-month forward earnings valuation of today's top 10 stocks in the S&P 500 is higher than it was 25 years ago. However, it's worth remembering that the dotcom bubble was characterised by a frenzy of public offerings and a raft of companies with shares valued at triple-digit multiples of future earnings. That's not the case today. While the S&P tech sector is trading at 29.5 times forward earnings today, which is high by historical standards, this is nowhere near the peak of almost 50 times recorded in 2000. Similarly, the S&P 500 and Nasdaq are currently trading around 22 and 28.5 times forward earnings, compared with the dotcom peaks of 24.5 and over 70 times, respectively. With all that being said, a meaningful, prolonged market correction cannot be ruled out, especially if AI-driven growth isn't delivered as quickly as investors expect. AI, the new driver of technological development, will require vast capital outlays, especially on data centres, which may mean that earnings and share price growth in tech could slow in the short run. According to Morgan Stanley, the transformative potential of generative AI will require roughly US$2.9 trillion of global data centre spending through 2028, comprising US$1.6 trillion on hardware like chips and servers and US$1.3 trillion on infrastructure. That means investment needs of over US$900 billion in 2028, they reckon. For context, combined capital expenditure by all S&P 500 companies last year was around US$950 billion. Wall Street analysts are well aware of these figures, which suggests that at least some percentage of these huge sums should be factored into current share prices and expected earnings, but what if the benefits of AI take longer to deliver? Or what if an upstart (remember China's DeepSeek?) dramatically shifts growth expectations for a major component of the index, like US$4-trillion chipmaker Nvidia? Of course, technology is so fundamental to today's society and economy that it's difficult to imagine its market footprint shrinking too much, for too long, as this raises the inevitable question of where investor capital would go.
Malaysian Reserve
7 hours ago
- Malaysian Reserve
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
BELLEVUE, Wash. and SEOUL, South Korea, July 24, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced it has signed a term sheet ('Term Sheet') with Woori IO Co., Ltd. ('WORIO'), a South Korean medical device company developing next-generation noninvasive glucose monitoring technology. The agreement sets forth certain key terms for a strategic acquisition of WORIO by OSR Holdings' Korean affiliate, OSR Holdings Co., Ltd. ('OSRK'). Under the proposed structure, WORIO will become a wholly owned subsidiary of OSRK. Shareholders of WORIO will receive newly issued shares of OSRK through the share exchange and may be eligible to convert them into OSRH common stock traded on NASDAQ, subject to certain conditions including '$10 per OSRH share' WORIO shareholders may convert their OSRK shares into OSRH shares at a fixed exchange ratio of 1 OSRK share = 12.96 OSRH shares, provided that OSRH's stock price reaches $10.00 at least once within three years following the signing of the Term Sheet. If this condition is not met, the parties have agreed to renegotiate in good faith. The agreement includes a 6-month exclusivity period, during which OSRK will conduct confirmatory legal and financial due diligence with a target to complete this transaction within this exclusivity proprietary platform uses near-infrared spectroscopy (NIRS) to measure glucose without needles, sensors, or skin penetration — representing a truly noninvasive alternative to today's continuous glucose monitors (CGMs). Its solution aims to eliminate the burden of pain and daily finger pricks for millions of people with diabetes. According to recent global market research, the blood glucose monitoring devices market is expected to exceed $40 billion by 2030, growing at a CAGR of 8–10%, driven by rising diabetes prevalence and the convergence of medical technology with consumer electronics. Demand for noninvasive and wearable monitoring systems is expected to be a major growth driver. Dexcom, one of the market leaders in minimally invasive CGM which is the current standard of care has more than $32 billion in market capitalization (as of July 11), underscoring the significant commercial potential of advanced glucose monitoring solutions. Noninvasive alternatives hold tremendous promise and are poised to become an integral part of diabetes management in the future. WORIO has completed a proof-of-concept study with the Korea University Hospital (Guro) to validate the accuracy and effectiveness of its prototype devices and the data measured by them, based on which the company plans to enter a larger confirmatory trial to be registered with the Ministry of Food and Drug Safety (MFDS) of Korea for medical device approval pathway. WORIO's noninvasive technology is well positioned to be integrated into wearable glucose monitoring devices such as smart watches — WORIO has been selected by Samsung Electronics' innovative startup program ('C-Lab Outside') in Q1 2025.'We believe this initial milestone with Woori IO aligns strongly with our mission to accelerate breakthrough healthcare innovations with global impact,' said Peter Hwang, CEO of OSRH. 'Woori IO's breakthrough noninvasive glucose monitoring platform, coupled with its high-profile partnership with global companies, puts OSRH in a position to become a first mover in this fast-growing global market.'Following the signing of this Term Sheet, both parties will proceed with due diligence and aim to execute definitive agreements within the 6 months exclusivity period. About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno-oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting-edge research and development. For more information, visit About Woori IO Co., Ltd. Woori IO is a medical device company based in Jeonju, South Korea, focused on the development of noninvasive biosensing solutions. Its proprietary NIRS-based glucose monitoring system enables accurate, pain-free, and user-friendly diabetes management, with strong potential for wearable integration. For more information, visit Contact:Investor RelationsOSR Holdings, IR@ Website:
Malaysian Reserve
8 hours ago
- Malaysian Reserve
CNX Reports Second Quarter Results
PITTSBURGH, July 24, 2025 /PRNewswire/ — CNX Resources Corporation (NYSE: CNX) ('CNX' or 'the company') today released financial and operational results for the second quarter of 2025 by posting those results on its website as detailed below. The company's second quarter prepared remarks can be accessed by clicking here. Second quarter earnings results and supplemental information regarding quarterly E&P data such as production volumes and hedging information, financial statements, and non-GAAP reconciliations can be accessed by clicking here. A company presentation to accompany its prepared remarks can be accessed by clicking here. The company's prepared remarks, earnings results and supplemental information, and presentation materials are also available on the Investor Relations page of the company's website at As previously disclosed, the CNX Q&A conference call details are as follows: 10:00 a.m. ET: Thursday, July 24 Dial-In: 855-656-0928 (domestic) 412-902-4112 (international) Reference 'CNX Resources Call' Webcast: A replay of the Q&A conference call and webcast will be maintained on the Investor Relations page on CNX's website. About CNX Resources Corporation CNX Resources Corporation (NYSE: CNX) is unique. We are a premier, ultra-low carbon intensive natural gas development, production, midstream, and technology company centered in Appalachia, one of the most energy abundant regions in the world. With the benefit of a 161-year regional legacy, substantial asset base, leading core operational competencies, technology development and innovation, and astute capital allocation methodologies, we responsibly develop our resources and deploy free cash flow to create long-term per share value for our shareholders, employees, and the communities where we operate. As of December 31, 2024, CNX had 8.54 trillion cubic feet equivalent of proved natural gas reserves. The company is a member of the Standard & Poor's Midcap 400 Index. Additional information is available at
